Newsroom | NeoGenomics Laboratories

August 23, 2023

Being hit by a TRuC can be a good thing:

Blog

August 8, 2023

NeoGenomics Reports Second Quarter 2023 Results

Press Release

July 27, 2023

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

Press Release

July 18, 2023

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

Press Release

July 3, 2023

Advancements in the Treatment of Glioblastoma Using Oncolytic Viruses

Blog

June 29, 2023

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

Press Release

June 28, 2023

CAR-T Cell Therapy in Oncology Applications

Blog

June 22, 2023

May Publications

Blog

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients